Evidence map›Paper›PMID 41458955›Full record

ArticleFrontiers in pharmacology2025

Correction: Terminal complement inhibition in atypical haemolytic uremic syndrome: a single-centre experience.

Valentin D Mocanu, Bogdan M Sorohan, Elena G Micu, Sonia Bălănică, Bogdan Obrişcă, Roxana A Jurubiță, Camelia A Achim, Adrian C Lungu, Cristina S Căpuşă, Gabriel Mircescu and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Valentin D MocanuNephrology Department, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Bogdan M SorohanNephrology Department, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Elena G MicuDepartment of Nephrology, Fundeni Clinical Institute, Bucharest, Romania.
Sonia BălănicăDepartment of Nephrology, Fundeni Clinical Institute, Bucharest, Romania.
Bogdan ObrişcăNephrology Department, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Roxana A JurubițăDepartment of Nephrology, Fundeni Clinical Institute, Bucharest, Romania.
Camelia A AchimNephrology Department, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Adrian C LunguDepartment of Nephrology, Fundeni Clinical Institute, Bucharest, Romania.
Cristina S CăpuşăNephrology Department, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Gabriel MircescuNephrology Department, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Gener IsmailNephrology Department, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fphar.2025.1683188.].

Indexed as

atypical hemolytic uremic syndromecomplement inhibitionend-stage kidney diseasegenetic mutationsthrombotic microangiopathy

Identifiers

PMID41458955
PMCPMC12739376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.